After a monumental vaccine discovery that allowed the world to see light at the end of the COVID-tunnel, how has Pfizer taken measures to stay ahead of the pandemic so that we can eventually put an end to COVID-19? From thinking differently about distribution to ensure an equitable rollout, to continued research on variants – this pivotal experience will forever impact the organization's approach to delivering breakthroughs for patients. How will their approach for other ground-breaking therapies evolve from the learnings of the pandemic? Pfizer's CEO, Albert Bourla, will share his vision for the future as well as the latest in the global vaccine rollout, ensuring equity and the most up to date data on the COVID-19 vaccine.